Article By:
Zacks Investment Research
Tuesday, September 16, 2014 4:53 PM EDT
On Sep 16, 2014, we issued an updated research report on life sciences company Illumina Inc. Illumina delivered strong second-quarter 2014 results with both the top and the bottom line surpassing the respective Zacks Consensus Estimate.